Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15538414

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is related to metabolically stable apelin analogs and their use for the prevention or the treatment of diseases mediated by the apelin receptor in particular of cardiovascular disease (heart failure, hypertension, pulmonary hypertension, kidney failure) and inappropriate vasopressin secretions (SIADH).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)3 RUE MICHEL ANGE PARIS 75016
UNIVERSITE DE STRASBOURG4 RUE BLAISE PASCAL STRASBOURG CEDEX 67081
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013
COLLEGE DE FRANCE75005 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BONNET, Dominique Strasbourg, FR 23 186
ITURRIOZ, Xavier Paris Cedex 5, FR 4 10
LLORENS-CORTES, Catherine Paris, FR 11 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation